{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:05:07Z","timestamp":1781712307321,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Basic Research Programs of China","award":["2016YFA0201200"],"award-info":[{"award-number":["2016YFA0201200"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["51525203"],"award-info":[{"award-number":["51525203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31300824"],"award-info":[{"award-number":["31300824"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012462","name":"Collaborative Innovation Center of Suzhou Nano Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012462","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Priority Academic Program Development (PAPD) of Jiangsu Higher Education Institutions"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biomaterials.2017.09.021","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T11:45:15Z","timestamp":1506167115000},"page":"69-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy"],"prefix":"10.1016","volume":"148","author":[{"given":"Qian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2017.09.021_bib1","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1158\/0008-5472.CAN-04-0074","article-title":"Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors","volume":"64","author":"Tong","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib3","doi-asserted-by":"crossref","first-page":"L555","DOI":"10.1152\/ajplung.00408.2001","article-title":"Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure","volume":"283","author":"Le Cras","year":"2002","journal-title":"Am. J. Physiol-Lung C"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib4","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3892\/ijo.2016.3709","article-title":"Antiangiogenic cancer treatment: the great discovery and greater complexity (Review)","volume":"49","author":"Maj","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib5","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1016\/j.biomaterials.2010.08.058","article-title":"Heparinized chitosan\/poly (\u03b3-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin","volume":"31","author":"Tang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.gde.2004.12.005","article-title":"Cellular abnormalities of blood vessels as targets in cancer","volume":"15","author":"Baluk","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nm988","article-title":"Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer","volume":"10","author":"Willett","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib9","first-page":"2010","article-title":"Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation","author":"Schmid","year":"2010","journal-title":"J.\u00a0Oncol."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib10","doi-asserted-by":"crossref","first-page":"17561","DOI":"10.1073\/pnas.1215397109","article-title":"Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy","volume":"109","author":"Huang","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib11","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","author":"Corzo","year":"2010","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia\u2014a key regulatory factor in tumour growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI40027","article-title":"The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5","volume":"120","author":"Rouschop","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib14","doi-asserted-by":"crossref","first-page":"E2784","DOI":"10.1073\/pnas.1202366109","article-title":"Hypoxia-inducible factor-1 alpha\u2013dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa","volume":"109","author":"Clambey","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nm1730","article-title":"Perivascular nitric oxide gradients normalize tumor vasculature","volume":"14","author":"Kashiwagi","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib17","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1021\/acs.nanolett.6b00820","article-title":"Hyaluronidase embedded in nanocarrier PEG shell for enhanced tumor penetration and highly efficient antitumor efficacy","volume":"16","author":"Zhou","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/gutjnl-2012-302604","article-title":"Improving drug delivery to pancreatic cancer: breaching the stromal fortress by targeting hyaluronic acid","volume":"61","author":"Michl","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biomaterials.2016.06.048","article-title":"Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer","volume":"103","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib21","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1021\/acs.nanolett.6b00068","article-title":"Hyaluronidase to enhance nanoparticle-based photodynamic tumor therapy","volume":"16","author":"Gong","year":"2016","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib22","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib23","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1158\/0008-5472.CAN-12-4354","article-title":"Vascular normalization as an emerging strategy to enhance cancer immunotherapy","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib24","first-page":"236","article-title":"PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter","volume":"63","author":"Pore","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib25","first-page":"5879","article-title":"Epidermal growth factor receptor (EGFR) transcriptionally upregulates VEGF expression in human glioblastoma cells via a pathway involving PI (3) kinase and distinct from that induced by hypoxia","volume":"60","author":"Maity","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib26","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/mt.2013.120","article-title":"Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC","volume":"21","author":"Zhang","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib28","doi-asserted-by":"crossref","first-page":"11399","DOI":"10.1073\/pnas.172398399","article-title":"Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma","volume":"99","author":"Kim","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib29","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/adma.201404308","article-title":"An imagable and photothermal \u201cAbraxane-Like\u201d nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors","volume":"27","author":"Chen","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2016.11.027","article-title":"Near-infrared light activation of quenched liposomal Ce6 for synergistic cancer phototherapy with effective skin protection","volume":"127","author":"Feng","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib31","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1158\/0008-5472.CAN-14-3304","article-title":"Erlotinib pretreatment improves photodynamic therapy of non-small cell lung carcinoma xenografts via multiple mechanisms","volume":"75","author":"Gallagher-Colombo","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib33","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1200\/JCO.2005.05.1474","article-title":"Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial","volume":"25","author":"Gatzemeier","year":"2007","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib34","first-page":"1045","article-title":"Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer","volume":"85","author":"Toi","year":"1994","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1158\/0008-5472.533.65.2","article-title":"Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine","volume":"65","author":"Weller","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/adma.201404308","article-title":"An imagable and photothermal \u201cAbraxane-Like\u201d nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors","volume":"27","author":"Chen","year":"2015","journal-title":"Adv. Mater"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cbpa.2012.03.016","article-title":"DNA aptamer functionalized nanomaterials for intracellular analysis, cancer cell imaging and drug delivery","volume":"16","author":"Xing","year":"2012","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib38","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1\u03b1 expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib39","article-title":"Drug-induced co-assembly of albumin\/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy","author":"Chen","year":"2016","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1148\/radiol.14140654","article-title":"Photoacoustic imaging of vascular hemodynamics: validation with blood oxygenation level\u2013dependent MR imaging","volume":"275","author":"Rich","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2015.10.009","article-title":"Immunotherapy and tumor microenvironment","volume":"370","author":"Tang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib42","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1158\/1078-0432.CCR-08-0229","article-title":"Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia","volume":"14","author":"Sitkovsky","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/0008-5472.CAN-13-1196","article-title":"Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population","volume":"74","author":"Laoui","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2741\/2692","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2007","journal-title":"Front. Biosci. J. Virtual Libr."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib45","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib46","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.12.005","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Nishikawa","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib48","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib50","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib51","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib52","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2017.09.021_bib53","first-page":"1","article-title":"In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy","author":"Wang","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib54","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib55","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti\u2013PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2017.09.021_bib56","doi-asserted-by":"crossref","first-page":"e6539","DOI":"10.1371\/journal.pone.0006539","article-title":"Epidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacy","volume":"4","author":"Cerniglia","year":"2009","journal-title":"PLoS One"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217306051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217306051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:29:32Z","timestamp":1758904172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961217306051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":56,"alternative-id":["S0142961217306051"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.021","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}